241 related articles for article (PubMed ID: 25510432)
21. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
Dong S; Tweardy DJ
Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
[TBL] [Abstract][Full Text] [Related]
22. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
[TBL] [Abstract][Full Text] [Related]
23. Trans-repressive effect of NUP98-PMX1 on PMX1-regulated c-FOS gene through recruitment of histone deacetylase 1 by FG repeats.
Bai XT; Gu BW; Yin T; Niu C; Xi XD; Zhang J; Chen Z; Chen SJ
Cancer Res; 2006 May; 66(9):4584-90. PubMed ID: 16651408
[TBL] [Abstract][Full Text] [Related]
24. Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.
Thanasopoulou A; Tzankov A; Schwaller J
Haematologica; 2014 Sep; 99(9):1465-71. PubMed ID: 24951466
[TBL] [Abstract][Full Text] [Related]
25. RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis.
Funasaka T; Nakano H; Wu Y; Hashizume C; Gu L; Nakamura T; Wang W; Zhou P; Moore MA; Sato H; Wong RW
Cell Cycle; 2011 May; 10(9):1456-67. PubMed ID: 21467841
[TBL] [Abstract][Full Text] [Related]
26. In vitro all-trans retinoic acid sensitivity of acute myeloid leukemia blasts with NUP98/RARG fusion gene.
Such E; Cordón L; Sempere A; Villamón E; Ibañez M; Luna I; Gómez-Seguí I; López-Pavía M; Alonso C; Lo-Coco F; Cervera J; Sanz MA
Ann Hematol; 2014 Nov; 93(11):1931-3. PubMed ID: 24728721
[No Abstract] [Full Text] [Related]
27. Function of Nup98 subtypes and their fusion proteins, Nup98-TopIIβ and Nup98-SETBP1 in nuclear-cytoplasmic transport.
Saito S; Yokokawa T; Iizuka G; Cigdem S; Okuwaki M; Nagata K
Biochem Biophys Res Commun; 2017 May; 487(1):96-102. PubMed ID: 28392395
[TBL] [Abstract][Full Text] [Related]
28. Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype.
Fahrenkrog B; Martinelli V; Nilles N; Fruhmann G; Chatel G; Juge S; Sauder U; Di Giacomo D; Mecucci C; Schwaller J
PLoS One; 2016; 11(3):e0152321. PubMed ID: 27031510
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes.
Du C; Redner RL; Cooke MP; Lavau C
Blood; 1999 Jul; 94(2):793-802. PubMed ID: 10397747
[TBL] [Abstract][Full Text] [Related]
30. Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions.
Yung E; Sekulovic S; Argiropoulos B; Lai CK; Leung M; Berg T; Vollett S; Chang VC; Wan A; Wong S; Humphries RK
Leuk Res; 2011 Apr; 35(4):545-50. PubMed ID: 21130494
[TBL] [Abstract][Full Text] [Related]
31. The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.
Liu X; Yuan H; Peres L; Chen S; Chen Z; de The H; Zhou J; Zhu J
PLoS One; 2014; 9(8):e104906. PubMed ID: 25119106
[TBL] [Abstract][Full Text] [Related]
32. Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.
Sarma NJ; Yaseen NR
J Biol Chem; 2011 Nov; 286(45):38989-9001. PubMed ID: 21937451
[TBL] [Abstract][Full Text] [Related]
33. RARA and RARG gene downregulation associated with EZH2 mutation in acute promyelocytic-like morphology leukemia.
Coccaro N; Zagaria A; Orsini P; Anelli L; Tota G; Casieri P; Impera L; Minervini A; Minervini CF; Cumbo C; Parciante E; Mestice A; Delia M; Brunetti C; Specchia G; Albano F
Hum Pathol; 2018 Oct; 80():82-86. PubMed ID: 29530751
[TBL] [Abstract][Full Text] [Related]
34. SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformation.
Jevtic Z; Matafora V; Casagrande F; Santoro F; Minucci S; Garre' M; Rasouli M; Heidenreich O; Musco G; Schwaller J; Bachi A
J Exp Clin Cancer Res; 2022 Jan; 41(1):34. PubMed ID: 35073946
[TBL] [Abstract][Full Text] [Related]
35. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
[TBL] [Abstract][Full Text] [Related]
36. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.
Pineault N; Buske C; Feuring-Buske M; Abramovich C; Rosten P; Hogge DE; Aplan PD; Humphries RK
Blood; 2003 Jun; 101(11):4529-38. PubMed ID: 12543865
[TBL] [Abstract][Full Text] [Related]
37. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation.
Kamashev D; Vitoux D; De Thé H
J Exp Med; 2004 Apr; 199(8):1163-74. PubMed ID: 15096541
[TBL] [Abstract][Full Text] [Related]
38. NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation.
Gurevich RM; Aplan PD; Humphries RK
Blood; 2004 Aug; 104(4):1127-36. PubMed ID: 15100157
[TBL] [Abstract][Full Text] [Related]
39. TGFbeta/BMP inhibits the bone marrow transformation capability of Hoxa9 by repressing its DNA-binding ability.
Wang N; Kim HG; Cotta CV; Wan M; Tang Y; Klug CA; Cao X
EMBO J; 2006 Apr; 25(7):1469-80. PubMed ID: 16525506
[TBL] [Abstract][Full Text] [Related]
40. MLL is essential for NUP98-HOXA9-induced leukemia.
Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
